Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Net Current Assets

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Net Current Assets (Including Current Investments) ₹325 Cr₹309 Cr₹303 Cr₹273 Cr₹22 Cr

What is the latest Net Current Assets ratio of NATH BIOGENES (INDIA) ?

The latest Net Current Assets ratio of NATH BIOGENES (INDIA) is ₹325 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹325 Cr
Mar2024₹309 Cr
Mar2023₹303 Cr
Mar2022₹273 Cr
Mar2013₹22 Cr

How is Net Current Assets of NATH BIOGENES (INDIA) Trending?

Years Net Current Assets % Change
Mar2025 ₹325 Cr
5.01
Mar2024 ₹309 Cr
1.92
Mar2023 ₹303 Cr
10.94
Mar2022 ₹273 Cr
1,164.10
Mar2013 ₹22 Cr -

Compare Net Current Assets of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹289.9 Cr 6.1% 8.6% -6.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,388.0 Cr 3.7% -3.1% -22.9% Stock Analytics
KAVERI SEED COMPANY ₹4,758.9 Cr 9% 20.6% -31.6% Stock Analytics
VENKYS (INDIA) ₹2,056.8 Cr 7.8% 15.4% -12.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,033.4 Cr -1.9% 18.1% -21.9% Stock Analytics
INDO US BIOTECH ₹214.9 Cr -1.1% 4.7% -30.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

6.1%

8.6%

-6.3%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses